TCWM
ANAB icon

Total Clarity Wealth Management’s AnaptysBio ANAB Stock Holding History

Total Clarity Wealth Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-350
Closed -$7K – 256
2022
Q2 		$7K Buy
+350
New +$7.75K ﹤0.01% 740
2022
Q1 		– Sell
-350
Closed -$12K – 247
2021
Q4 		$12K Hold
350
– – 0.01% 645
2021
Q3 		$9K Buy
+350
New +$8.88K ﹤0.01% 692
2021
Q2 		– Sell
-350
Closed -$8K – 218
2021
Q1 		$8K Buy
+350
New +$8.83K ﹤0.01% 592

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Total Clarity Wealth Management's ANAB Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of AnaptysBio (ANAB) in Q3 2022, closing a stake of 350 shares — an estimated $7K sold.

Total Clarity Wealth Management first reported a position in ANAB in Q1 2021 and held it in 4 quarters. The position peaked at $12K in Q4 2021. 114 funds tracked by Wall St. Rank hold ANAB as of Q3 2022.

  • Total Clarity Wealth Management reported no remaining AnaptysBio position as of Q3 2022 after selling out during the quarter.
  • Total Clarity Wealth Management sold 350 AnaptysBio shares in Q3 2022, an estimated $7K.
  • Total Clarity Wealth Management first reported a position in AnaptysBio in Q1 2021 and held it in 4 quarters.
  • Total Clarity Wealth Management's AnaptysBio position peaked at $12K in Q4 2021.
  • 114 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.